LEADER 00840nam0-2200313---450- 001 990009979500403321 005 20150629093924.0 010 $a978-88-430-7491-4 035 $a000997950 035 $aFED01000997950 035 $a(Aleph)000997950FED01 035 $a000997950 100 $a20150629d2015----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $a<>pensiero ebraico nel Novecento$fa cura di Adriano Fabris 210 $aRoma$cCarocci$d2015 215 $a343 p.$d22 cm 225 1 $aFrecce$v196 610 0 $aEbraismo$aSec. 20. 676 $a181.06$v22$zita 702 1$aFabris,$bAdriano$f<1958- > 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a990009979500403321 952 $aCollez. 2161 (196)$b397/2015$fFSPBC 959 $aFSPBC 997 $aUNINA LEADER 02018nam 2200553Ia 450 001 9910699905303321 005 20110502160537.0 035 $a(CKB)5470000002406908 035 $a(OCoLC)719388586 035 $a(OCoLC)869387916 035 $a(EXLCZ)995470000002406908 100 $a20110502d2010 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHeat entrapment effects within liquid acquisition devices$b[electronic resource] /$fW.M.B. Duval, D.J. Chato, and M.P. Doherty ; prepared for the 48th Aerospace Sciences Meeting sponsored by the American Institute of Aeronautics and Astronautics, Orlando, Florida, January 4-7, 2010 205 $a[Revised edition]. 210 1$aCleveland, Ohio :$cNational Aeronautics and Space Administration, Glenn Research Center,$d[2010] 215 $a1 online resource (29 pages) $cillustrations, color 225 1 $aNASA/TM ;$v2010-216789 300 $aTitle from title screen (viewed on May 2, 2011). 300 $a"September 2010." 300 $a"AIAA-2010-1298." 320 $aIncludes bibliographical references (pages 28-29). 606 $aEntrapment$2nasat 606 $aHeat flux$2nasat 606 $aMathematical models$2nasat 606 $aLiquids$2nasat 606 $aCryogenics$2nasat 606 $aFlow distribution$2nasat 615 7$aEntrapment. 615 7$aHeat flux. 615 7$aMathematical models. 615 7$aLiquids. 615 7$aCryogenics. 615 7$aFlow distribution. 700 $aDuval$b Walter M. B$01399283 701 $aD.J. Chato$01417688 701 $aDoherty$b M. P$01417689 712 02$aNASA Glenn Research Center. 712 12$aAIAA Aerospace Sciences Meeting$d(48th :$f2010 :$eOrlando, Fla.) 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910699905303321 996 $aHeat entrapment effects within liquid acquisition devices$93526957 997 $aUNINA LEADER 04556nam 22008415 450 001 9910300235703321 005 20250715123300.0 010 $a94-017-9168-6 024 7 $a10.1007/978-94-017-9168-7 035 $a(CKB)3710000000291724 035 $a(EBL)1967009 035 $a(OCoLC)908086571 035 $a(SSID)ssj0001386398 035 $a(PQKBManifestationID)11809738 035 $a(PQKBTitleCode)TC0001386398 035 $a(PQKBWorkID)11373809 035 $a(PQKB)11236991 035 $a(DE-He213)978-94-017-9168-7 035 $a(MiAaPQ)EBC1967009 035 $a(PPN)183092554 035 $a(EXLCZ)993710000000291724 100 $a20141118d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCirculating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring $eAn Introduction /$fedited by Peter B. Gahan 205 $a1st ed. 2015. 210 1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2015. 215 $a1 online resource (476 p.) 225 1 $aAdvances in Predictive, Preventive and Personalised Medicine,$x2211-3509 ;$v5 300 $aDescription based upon print version of record. 311 08$a94-017-9167-8 320 $aIncludes bibliographical references at the end of each chapters and indexes. 327 $aPart I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4. Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS ? DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics. 330 $aDNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals.  Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up.  In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: ·      Background and general biology of circulating nucleic acids ·      Methodology ·      Applications of circulating nucleic acids ·      Quality Assurance ·      Ethics. 410 0$aAdvances in Predictive, Preventive and Personalised Medicine,$x2211-3509 ;$v5 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aMedicine, Preventive 606 $aHealth promotion 606 $aCancer 606 $aBiomaterials 606 $aNucleic acids 606 $aPharmaceutical chemistry 606 $aBiomedical Research 606 $aHealth Promotion and Disease Prevention 606 $aCancer Biology 606 $aNucleic Acid 606 $aMedicinal Chemistry 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 0$aMedicine, Preventive. 615 0$aHealth promotion. 615 0$aCancer. 615 0$aBiomaterials. 615 0$aNucleic acids. 615 0$aPharmaceutical chemistry. 615 14$aBiomedical Research. 615 24$aHealth Promotion and Disease Prevention. 615 24$aCancer Biology. 615 24$aNucleic Acid. 615 24$aMedicinal Chemistry. 676 $a612.0157 702 $aGahan$b Peter B$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910300235703321 996 $aCirculating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring$91760683 997 $aUNINA